Clinical Trial Update: TDF Dose Adjustment VS. Switching to TAF in TDF-experienced CHB Patients With Renal Impairment [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing tenofovir disoproxil fumarate (TDF) dose adjustment versus switching to tenofovir alafenamide (TAF) in TDF-experienced chroni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• TAF switch (tenofovir alafenamide)
• TDF dose adjustment (tenofovir disoproxil fumarate)

Snippet

Sponsor: Mahidol University | Conditions: Renal Insufficiency, Tenofovir | Phase 4 | Status: UNKNOWN